Christina Larkin

2018

In 2018, Christina Larkin earned a total compensation of $533.8K as Chief Operating Officer at Spero Therapeutics, a 56% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$148,225
Salary$385,000
Other$574
Total$533,799

Larkin received $385K in salary, accounting for 72% of the total pay in 2018.

Larkin also received $148.2K in non-equity incentive plan and $574 in other compensation.

Rankings

In 2018, Christina Larkin's compensation ranked 11,663rd out of 14,244 executives tracked by ExecPay. In other words, Larkin earned more than 18.1% of executives.

ClassificationRankingPercentile
All
11,663
out of 14,244
18th
Division
Manufacturing
4,705
out of 5,762
18th
Major group
Chemicals And Allied Products
1,780
out of 2,125
16th
Industry group
Drugs
1,516
out of 1,814
16th
Industry
Pharmaceutical Preparations
1,164
out of 1,388
16th
Source: SEC filing on September 30, 2020.

Larkin's colleagues

We found three more compensation records of executives who worked with Christina Larkin at Spero Therapeutics in 2018.

2018

David Melnick

Spero Therapeutics

Chief Medical Officer

2018

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

2018

Cristina Larkin

Spero Therapeutics

Chief Operating Officer

News

You may also like